AJTMH ASTMH MEMBERSHIP INFORMATION: astmh@astmh.org
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am. J. Trop. Med. Hyg., 28(1), 1979, pp. 19-23
Copyright © 1979 by The American Society of Tropical Medicine and Hygiene

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kavousi, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kavousi, S.

Giardiasis in Infancy and Childhood: A Prospective Study of 160 Cases with Comparison of Quinacrine (Atabrine®) and Metronidazole (Flagyl®)*

Siavash Kavousi
Department of Pediatrics, Pahlavi University, School of Medicine, Shiraz, Iran

The therapeutic effects of quinacrine (Atabrine®) and metronidazole (Flagyl®) were compared in a 3-year prospective study of 160 infants and children (86 boys and 74 girls ranging in age from 4.5 months to 13 years) with giardiasis. The most common symptom was recurrent abdominal pain. In each study group stool examinations were done 5 days, 1 month, and 6 months after treatment. There were no treatment failures with metronidazole, whereas four of those treated with quinacrine had positive stools 5 days after treatment, indicating possible failure. There were no recurrences at 1 month; after 6 months, however, Giardia infection was found in 13% of both treatment groups. These recurrences were seen mainly in children from families with other infected members. Considering the low failure rate, the minimal side effects, and the relatively more tolerable flavor, metronidazole seems to be preferrable in the treatment of giardiasis. A dosage of 15–25 mg/kg a day for 5 days is recommended.

Accepted for publication August 12, 1978.


* Address reprint requests to: Siavash Kavousi, M.D., Department of Pediatrics, Nemazee Hospital, Shiraz, Iran.




This article has been cited by other articles:


Home page
 CLIN PEDIATRHome page
S. J. Lerman and R. A. Walker
Treatment of Giardiasis: Literature Review and Recommendations
Clinical Pediatrics, July 1, 1982; 21(7): 409 - 414.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the American Society of Tropical Medicine and Hygiene.